A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis

on behalf of the AIFA’s Monitoring Registries Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences